Bill
Bill > A4057
NJ A4057
NJ A4057Requires hospitals to test for fentanyl and xylazine as part of urine drug screenings.
summary
Introduced
03/11/2024
03/11/2024
In Committee
05/13/2024
05/13/2024
Crossed Over
Passed
Dead
01/12/2026
01/12/2026
Introduced Session
2024-2025 Regular Session
Bill Summary
Requires hospitals to test for fentanyl and xylazine as part of urine drug screenings.
AI Summary
This bill requires hospitals in New Jersey to test for fentanyl and xylazine as part of urine drug screenings conducted on patients. It also requires hospitals to report the test results, which will be de-identified, to the Department of Health. The bill provides that hospitals without the necessary analyzer equipment can use fentanyl, xylazine, or other drug test strips to comply with the new requirements. Additionally, the bill specifies that it does not affect existing laws related to opioid drugs, drug overdoses, and other substances.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (5)
Dawn Fantasia (R)*,
Julio Marenco (D)*,
Anthony Verrelli (D)*,
Shanique Speight (D),
Chris Tully (D),
Last Action
Reported out of Asm. Comm. with Amendments, and Referred to Assembly Financial Institutions and Insurance Committee (on 05/13/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2024/A4057 |
| BillText | https://pub.njleg.gov/Bills/2024/A4500/4057_R1.HTM |
| Analysis - Statement AHE 5/13/24 | https://pub.njleg.gov/Bills/2024/A4500/4057_S1.PDF |
| BillText | https://pub.njleg.gov/Bills/2024/A4500/4057_I1.HTM |
Loading...